Skip to main content

Oncosec Medical Inc

ONCSDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001444307

Oncosec Medical Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Feb 9, 2023; 23 institutions reported holding it in 13F filings for Q3 2022, worth $2.51M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Oncosec Medical Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ONCS: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3536+1
Shares7.59M6.82M−773.7K (−10.2%)
Value$36.2M$19.2M−$17.0M (−47.1%)

New holders (8)

Institutions that held Oncosec Medical Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ONCS in Q2 2021
InstitutionSharesValue% of portfolio
Boothbay Fund Management, LLC45,370$127.0K0.01%
Gsa Capital Partners LLP29,643$83.0K0.01%
Shay Capital LLC25,057$70.0K0.02%
State Street Corp19,929$56.0K0.00%
Envestnet Asset Management Inc13,486$38.0K0.00%
Virtu Financial LLC12,649$36.0K0.00%
Citigroup Inc4,100$12.0K0.00%
Tower Research Capital LLC (TRC)4,178$12.0K0.00%

Sold out (7)

Institutions that held Oncosec Medical Inc at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ONCS in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Stonepine Capital Management, LLC94,783$452.0K
Squarepoint Ops LLC52,024$248.0K
ExodusPoint Capital Management, LP32,559$155.0K
Price T Rowe Associates Inc11,400$54.0K
Sowell Financial Services LLC3,242$13.0K
Barclays PLC884$4.00K
Wealthcare Advisory Partners LLC150$1.00K